Biotech Archives - Page 2 of 795

2 minute read

Teva Engages In Settlement Talks Over Medicare Kickback Allegations

June 18, 2:24 PM

Teva Pharmaceutical is negotiating with the DOJ to settle a lawsuit alleging it paid kickbacks through charities to boost Copaxone sales, risking up to $10 billion in damages.

TEVA

2 minute read

Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs

By Vandana Singh

June 18, 1:44 PM

Discover Cantor Fitzgerald's analysis on Innoviva, highlighting its unique royalty-based business model with GSK for asthma and COPD products.

GSK

2 minute read

What’s Going On With Small-Cap Cancer Focused XBiotech On Tuesday?

By Vandana Singh

June 18, 1:08 PM

XBiotech reveals results from its Phase 1/Phase 2 1-BETTER Study for advanced pancreatic cancer, highlighting the safety and tolerability of Natrunix with the ONIVYDE + 5-Fluorouracil + Leucovorin regimen.

XBIT

2 minute read

Obesity In Children – US Parents Face Tough Time To Access Recommended Treatment, Though Novo Nordisk’s Drug Still Sees Strong Demand

By Vandana Singh

June 18, 12:30 PM

U.S. parents face significant barriers to accessing intensive behavioral counseling for childhood obesity, with programs often unavailable, not covered by insurance, and requiring substantial time commitments.

NVO

1 minute read

XBiotech Shares Results From Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment For Advanced Pancreatic Cancer

By Benzinga Newsdesk

June 18, 11:48 AM

XBiotech (NASDAQ:XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for advanced pancreatic cancer. Known as 1-BETTER, the study examined Natrunix

XBIT

2 minute read

What’s Going On With Taysha Gene Therapies Stock Tuesday?

By Vandana Singh

June 18, 11:42 AM

Taysha Gene Therapies reveals promising longer-term and initial clinical data from their REVEAL Phase 1/2 trials evaluating TSHA-102 for Rett syndrome.

TSHA

1 minute read

‘Corning Announces Collaboration With NIBRT To Help Accelerate Cell Therapy Development’

By Benzinga Newsdesk

June 18, 10:48 AM

https://www.corning.com/worldwide/en/about-us/news-events/news-releases/2024/06/corning-announces-collaboration-with-nibrt-to-help-accelerate-cell-therapy-development.htmlCorning's cutting-edge Ascent® Fixed Bed

GLW

2 minute read

Intra-Cellular Therapies’ Highlights Successful Data From Second Depression Study

By Vandana Singh

June 18, 10:37 AM

Intra-Cellular Therapies reports positive topline results for Study 502 on lumateperone 42 mg as adjunctive therapy for major depressive disorder. FDA application expected in H2 2024.

ITCI

1 minute read

Neurogene Reports First Patient Dosed In High-Dose Cohort Of NGN-401 Gene Therapy Clinical Trial For Rett Syndrome

By Benzinga Newsdesk

June 18, 9:28 AM

High-dose NGN-401 has been well-tolerated, and low-dose NGN-401 continues to show a favorable safety profileInterim safety data presented at the International Rett Syndrome Foundation (IRSF) ASCEND SummitNeurogene Inc.

NGNE

2 minute read

AstraZeneca’s Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial

By Vandana Singh

June 18, 9:22 AM

AstraZeneca announced that the CAPItello-290 Phase 3 trial for Truqap (capivasertib) combined with paclitaxel in advanced or metastatic triple-negative breast cancer did not meet primary endpoints for overall survival.

AZN